139 related articles for article (PubMed ID: 6639888)
1. Preservation of deformability (filterability) of sickle cells by BW12C during progressive deoxygenation.
Kenny MW; Stuart J
Br J Haematol; 1983 Nov; 55(3):465-71. PubMed ID: 6639888
[TBL] [Abstract][Full Text] [Related]
2. Effect of BW12C on oxygen affinity of haemoglobin in sickle-cell disease.
Keidan AJ; Franklin IM; White RD; Joy M; Huehns ER; Stuart J
Lancet; 1986 Apr; 1(8485):831-4. PubMed ID: 2870317
[TBL] [Abstract][Full Text] [Related]
3. Pharmacological modification of oxygen affinity improves deformability of deoxygenated sickle erythrocytes: a possible therapeutic approach to sickle cell disease.
Keidan AJ; Sowter MC; Johnson CS; Marwah SS; Stuart J
Clin Sci (Lond); 1989 Apr; 76(4):357-62. PubMed ID: 2714049
[TBL] [Abstract][Full Text] [Related]
4. Fluctuating deformability of oxygenated sickle erythrocytes in the asymptomatic state and in painful crisis.
Lucas GS; Caldwell NM; Stuart J
Br J Haematol; 1985 Feb; 59(2):363-8. PubMed ID: 3970860
[TBL] [Abstract][Full Text] [Related]
5. Perfluorocarbon compounds: effects on the rheological properties of sickle erythrocytes in vitro.
Reindorf CA; Kurantsin-Mills J; Allotey JB; Castro O
Am J Hematol; 1985 Jul; 19(3):229-36. PubMed ID: 4014223
[TBL] [Abstract][Full Text] [Related]
6. Substituted benzaldehydes (12C79 and 589C80) that stabilize oxyhaemoglobin also protect sickle cells against calcium-mediated dehydration.
Stone PC; Nash GB; Stuart J
Br J Haematol; 1992 Jul; 81(3):419-23. PubMed ID: 1390217
[TBL] [Abstract][Full Text] [Related]
7. Exposure of blood from patients with sickle cell disease to air changes the morphological, oxygen-binding, and sickling properties of sickled erythrocytes.
Obata K; Mattiello J; Asakura K; Ohene-Frempong K; Asakura T
Am J Hematol; 2006 Jan; 81(1):26-35. PubMed ID: 16369974
[TBL] [Abstract][Full Text] [Related]
8. Effects of hemoglobin concentration on deformability of individual sickle cells after deoxygenation.
Itoh T; Chien S; Usami S
Blood; 1995 Apr; 85(8):2245-53. PubMed ID: 7718897
[TBL] [Abstract][Full Text] [Related]
9. Sickling in vitro at venous and arterial oxygen tensions of reticulocytes from patients with sickle cell disease.
Onyike AE; Ohene-Frempong K; Horiuchi K
Biochem Biophys Res Commun; 1995 Jun; 211(2):504-10. PubMed ID: 7794262
[TBL] [Abstract][Full Text] [Related]
10. Polymerization of sickle cell hemoglobin at arterial oxygen saturation impairs erythrocyte deformability.
Green MA; Noguchi CT; Keidan AJ; Marwah SS; Stuart J
J Clin Invest; 1988 Jun; 81(6):1669-74. PubMed ID: 3384944
[TBL] [Abstract][Full Text] [Related]
11. Characterization of Sickling During Controlled Automated Deoxygenation with Oxygen Gradient Ektacytometry.
Rab MAE; van Oirschot BA; Bos J; Kanne CK; Sheehan VA; van Beers EJ; van Wijk R
J Vis Exp; 2019 Nov; (153):. PubMed ID: 31762454
[TBL] [Abstract][Full Text] [Related]
12. Filterability of freshly-collected sickle erythrocytes under venous oxygen pressure without exposure to air.
Shah S; Acholonu RG; Ohene-Frempong K; Asakura T
Blood Cells Mol Dis; 2015 Dec; 55(4):328-35. PubMed ID: 26460256
[TBL] [Abstract][Full Text] [Related]
13. Substituted benzaldehydes designed to increase the oxygen affinity of human haemoglobin and inhibit the sickling of sickle erythrocytes.
Beddell CR; Goodford PJ; Kneen G; White RD; Wilkinson S; Wootton R
Br J Pharmacol; 1984 Jun; 82(2):397-407. PubMed ID: 6733364
[TBL] [Abstract][Full Text] [Related]
14. Rapid and reproducible characterization of sickling during automated deoxygenation in sickle cell disease patients.
Rab MAE; van Oirschot BA; Bos J; Merkx TH; van Wesel ACW; Abdulmalik O; Safo MK; Versluijs BA; Houwing ME; Cnossen MH; Riedl J; Schutgens REG; Pasterkamp G; Bartels M; van Beers EJ; van Wijk R
Am J Hematol; 2019 May; 94(5):575-584. PubMed ID: 30784099
[TBL] [Abstract][Full Text] [Related]
15. Effects of an increase in haemoglobin O2 affinity produced by BW12C on myocardial function in the erythrocyte-perfused rabbit heart in vitro and myocardial infarct size in the dog.
Allan G; Chapple DJ; Hughes B
Br J Pharmacol; 1986 Sep; 89(1):183-90. PubMed ID: 3801772
[TBL] [Abstract][Full Text] [Related]
16. Deformability of sickle cells as studied by microsieving.
Usami S; Chien S; Bertles JF
J Lab Clin Med; 1975 Aug; 86(2):274-9. PubMed ID: 1151150
[TBL] [Abstract][Full Text] [Related]
17. Erythrocyte heterogeneity in sickle cell disease: effect of deoxygenation on intracellular polymer formation and rheology of sub-populations.
Keidan AJ; Noguchi CT; Player M; Chalder SM; Stuart J
Br J Haematol; 1989 Jun; 72(2):254-9. PubMed ID: 2757967
[TBL] [Abstract][Full Text] [Related]
18. Filterability of sickle cells as a function of pO2: role of physico-chemical factors.
Kraiem A; Craescu CT; Galacteros F; Martin-Caburi J; Domenget C; Garel MC; Beuzard Y
Biorheology; 1989; 26(4):771-84. PubMed ID: 2611370
[TBL] [Abstract][Full Text] [Related]
19. Additive in vitro effects of anti-sickling drugs.
Stuart J; Mojiminiyi FB; Stone PC; Culliford SJ; Ellory JC
Br J Haematol; 1994 Apr; 86(4):820-3. PubMed ID: 7918079
[TBL] [Abstract][Full Text] [Related]
20. Effect of alpha thalassaemia on the rheology of homozygous sickle cell disease.
Serjeant BE; Mason KP; Kenny MW; Stuart J; Higgs DR; Weatherall DJ; Hayes RJ; Serjeant GR
Br J Haematol; 1983 Nov; 55(3):479-86. PubMed ID: 6639889
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
